The significant elevated expression of SPP1 and HMOX1 was detected in the samples diagnosed with classified as WHO G4/G3 gliomas in comparison to those with G2 glioma tissues (p < 0.001, Figure 3D). Here, SPP1 is linked to central nervous system cancer.